| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 11/19/2008 | EP1373510B1 Mutant allergens |
| 11/19/2008 | EP1358213B1 Humanized antibodies that recognize beta amyloid peptide |
| 11/19/2008 | EP1330475B1 Neuromedin u delta polypeptides |
| 11/19/2008 | EP1206555B1 Fv antibody construct comprising binding sites for a cd16 receptor and a cd30 surface protein |
| 11/19/2008 | EP1112084B1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 11/19/2008 | EP0983512B1 Method for identifying compounds binding to the chaperonin CCT |
| 11/19/2008 | EP0925073B1 Staphylococcus aureus antigen |
| 11/19/2008 | CN101309934A 修饰的伴侣蛋白10 Modified chaperonin 10 |
| 11/19/2008 | CN101309933A Toxin conjugated eph receptor antibodies |
| 11/19/2008 | CN101309929A A marker for prolonged rupture of membranes |
| 11/19/2008 | CN101309703A 抗cd3抗体组合物 Anti-cd3 antibody compositions |
| 11/19/2008 | CN101307312A Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 11/19/2008 | CN101307304A Anti-human ovarian carcinoma anti-anti-idiotype antibody hybridoma cell line, and monoclonal antibody and application thereof |
| 11/19/2008 | CN101307303A Kit for detecting clenobuterol hydrochloride residue and method for preparing same |
| 11/19/2008 | CN101307109A Mouse-anti-human T lymphocyte CD3 surface antigen monoclonal antibodies, method for preparing same and use |
| 11/19/2008 | CN101307108A Anti-phosphorylation Tau protein antibody use for detecting AD sign abnormal phosphation Tau protein level |
| 11/19/2008 | CN101307107A Protein tau |
| 11/19/2008 | CN101307104A Recombination escherichia coli with Z9CCK protein, yolk antibody and applications |
| 11/19/2008 | CN101306200A Preparation method of hepatitis b human immunoglobulin for intravenous injection |
| 11/19/2008 | CN100434441C Inhibition of viral infection using monovalent antigen-binding proteins |
| 11/19/2008 | CN100434440C Antibodies directed to tumor necrosis factor and uses thereof |
| 11/19/2008 | CN100434439C Genes and polypeptides relating to chronic myeloid leukemia |
| 11/19/2008 | CN100434438C Preparation method of CYP1A2 polypeptide and antihuman CYP1A2 polypeptide antibody |
| 11/19/2008 | CN100434432C Process for preparing ethyl parathion artificial semi antigen, artificial antigen, antibody and their use |
| 11/18/2008 | US7452982 An immunogenic complex characterised in that an enzyme is integrated into an immunostimulating complex (ISCOM) containing a glycoside, a lipid and an antigen |
| 11/18/2008 | US7452981 derived from mouse monoclonal anti-CD4 antibody B-F5 is able to activate CD25+CD4+ regulatory T cells; rheumatoid arthritis, type I diabetes, multiple sclerosis, Crohn's disease, ulcerative colitis, atopic dermatitis, etc. |
| 11/18/2008 | US7452980 Compositions and methods for the diagnosis and treatment of immune disorders |
| 11/18/2008 | US7452979 Cancerous disease modifying antibodies |
| 11/18/2008 | US7452978 Cancerous disease modifying antibodies |
| 11/18/2008 | US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα |
| 11/18/2008 | US7452976 Immunoglobulin specific to kinase insert domain-containing receptor (KDR) for use in treatment and prevention of inflammation, psoriasis, rheumatoid arthritis and tumor growth; immunotherapy |
| 11/18/2008 | US7452975 Induction of chrondrocyte proliferation/differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis |
| 11/18/2008 | US7452974 Drug targets related to synthase subfamily; alternative splice forms; isolated peptides and antibodies |
| 11/18/2008 | US7452971 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 11/18/2008 | US7452963 From 7 to 50 amino acids comprising: (1) a lysine residue six to ten residues from a second lysine residue; (2) a histidine residue; and (3) at least 6% lysine residues |
| 11/18/2008 | US7452693 Used in antibacterial, immunosuppressant, and antitumor drug making; loading an extender molecule on an acyl carrier protein (ACP) domain |
| 11/18/2008 | US7452685 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment |
| 11/18/2008 | US7452684 Collagen XXII, a novel human collagen and uses thereof |
| 11/18/2008 | US7452681 identifying markers indicative of the risk of developing a neurodevelopmental disorder caused in part by antibody- or autoantibody-mediated damage of neural tissue |
| 11/18/2008 | US7452679 Hybridization; phage display; spectroscopy |
| 11/18/2008 | US7452677 for the identification and isolation of chondrocytes, mesenchymal progenitor cells and embryonic stem cells for tissue engineering of cartilage; diseases related to joints, cartilage and atherosclerosis |
| 11/18/2008 | US7452676 Monoclonal antibodies to RNA binding protein GW182 |
| 11/18/2008 | US7452540 Enhanced immunization and suppression of oral tolerance |
| 11/18/2008 | US7452539 Performing polypeptide exposure to urea in the presence of a glycine containing solution to deactivate viral contaminants |
| 11/18/2008 | US7452538 Death domain containing receptor 4 antibodies and methods |
| 11/18/2008 | US7452537 Modulation of P-cadherin mediated adhesion and intracellular signaling is expected to result in decreased proliferation and survival of tumor cells in vivo |
| 11/18/2008 | US7452536 Inhibiting OX-2 (also called CD200) gene expression to treat a tumor that is associated with increased CD200 expression; leukemia; phage display screening for antigens; monoclonal antibodies; fusion proteins; use of OX-2 preventing graft rejection, autoimmune disease, and in inducing tumor cell growth |
| 11/18/2008 | US7452535 Methods of treatment using CTLA-4 antibodies |
| 11/18/2008 | US7452534 low antigenicity, reduced (or absent) T cell depleting activity, good affinity to human CD4 and enhanced stability (in vivo half-life); chimeric antibodies contain Old World monkey variable sequences and human constant domain sequences |
| 11/18/2008 | US7452530 Administering a blocking agent of tumor necrosis factors or receptors; treatment of Sin Nombre (SNV), Ebola, Marburg, Lassa, and Dengue viral disease |
| 11/18/2008 | CA2588106A1 Single-domain antibodies and heavy chain antibody against egfr and uses thereof |
| 11/18/2008 | CA2344166C Compositions of .beta.-glucans and specific igiv |
| 11/18/2008 | CA2288234C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 11/18/2008 | CA2210491C Antagonists of interleukin-15 |
| 11/18/2008 | CA2172376C Antibodies to cd40 |
| 11/18/2008 | CA2156495C Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells |
| 11/18/2008 | CA2136230C Clostridium perfringens vaccines |
| 11/18/2008 | CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 11/18/2008 | CA2095421C Novel amyloid precursor proteins and methods of using same |
| 11/13/2008 | WO2008137915A2 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 11/13/2008 | WO2008137881A2 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 11/13/2008 | WO2008137475A2 Immunoglobulin fc libraries |
| 11/13/2008 | WO2008137382A1 Anti-tissue factor antibodies and compositions with enhanced effector function |
| 11/13/2008 | WO2008137338A1 CRIg ANTAGONISTS |
| 11/13/2008 | WO2008137165A1 Anti-glycated cd59 antibodies and uses thereof |
| 11/13/2008 | WO2008136848A2 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
| 11/13/2008 | WO2008136774A1 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide |
| 11/13/2008 | WO2008136736A2 Immunoregulatory structures from normally occurring proteins |
| 11/13/2008 | WO2008136694A1 Engineered rabbit antibody variable domains and uses thereof |
| 11/13/2008 | WO2008136510A1 Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes |
| 11/13/2008 | WO2008136345A1 Polypeptide capable of improving tolerance to iron deficiency in plant, and use thereof |
| 11/13/2008 | WO2008135446A2 Klebsiella antigens |
| 11/13/2008 | WO2008135419A2 Anti-il-6-agents for improving primary functioning of allogenic grafts |
| 11/13/2008 | WO2008135259A2 Antibody molecule composition |
| 11/13/2008 | WO2008134876A1 Cancerous disease modifying antibodies |
| 11/13/2008 | WO2008118792A3 Gamma delta t cells and methods of treatment of interleukin-17 related conditions |
| 11/13/2008 | WO2008113515A3 huTNFR1 SELECTIVE ANTAGONISTS |
| 11/13/2008 | WO2008104183A3 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 11/13/2008 | WO2008094964A3 Cancer therapy prognosis |
| 11/13/2008 | WO2008086034A3 Antibody-based gamma-hydroxybutyrate (ghb) detection method and device |
| 11/13/2008 | WO2008081331A3 Enhancing the level of antibody expression by framework re-engineering |
| 11/13/2008 | WO2008075174A3 Lysosomal associated membrane protein (lamp) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells |
| 11/13/2008 | WO2008073988A3 Nmdar biomarkers for diagnosis and treatment of traumatic brain injury and other disorders |
| 11/13/2008 | WO2008070727A3 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same |
| 11/13/2008 | WO2008061020A9 Methods of treating, diagnosing or detecting cancer |
| 11/13/2008 | WO2008061013A3 Antibody-based diagnostics and therapeutics |
| 11/13/2008 | WO2008052933A3 Prevention of aggregation of immunoglobulin light or heavy chains |
| 11/13/2008 | WO2008052111A3 Resistin antagonists and their use |
| 11/13/2008 | WO2008045437A9 Chimeric t-cell receptors and t-cells targeting egfrviii on tumors |
| 11/13/2008 | WO2008042024A3 Neuroactive fragments of app |
| 11/13/2008 | WO2008030558A3 Modified human plasma polypeptide or fc scaffolds and their uses |
| 11/13/2008 | WO2008030543A3 Tyrosine, serine and threonine phosphorylation sites |
| 11/13/2008 | WO2008021976A3 Anti-interferon alpha monoclonal antibodies and methods for use |
| 11/13/2008 | WO2008021160B1 Regulation of litaf modulated cytokine production by a novel p53 short peptide |
| 11/13/2008 | WO2008019315A3 Improved pre-implantation genetic diagnosis test |
| 11/13/2008 | WO2008006036A3 Conditioned cell immunization |
| 11/13/2008 | WO2007126958A3 Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites |
| 11/13/2008 | WO2007101094A3 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome |
| 11/13/2008 | WO2007041635A3 Fc variants with optimized fc receptor binding properties |
| 11/13/2008 | WO2005072129A3 Production of host cells containing mutiple integrating vectors by serial transduction |